Related Experiment Video
Updated: Nov 25, 2025
08:04
In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function
Published on: February 27, 2019
12.3K
Predicting CAR-T cell Immunotherapy Success through ImmunoPET.
Alessia Volpe1, Veronica L Nagle2, Jason S Lewis1,2,3
1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Summary
Chimeric antigen receptor (CAR)-T cell therapy shows promise for blood cancers. New noninvasive positron emission tomography (PET) imaging methods are needed to track these engineered T cells within the body.
Area of Science:
- Oncology
- Immunotherapy
- Medical Imaging
Background:
- Chimeric antigen receptor (CAR)-T cell therapy has revolutionized hematologic cancer treatment.
- Effective monitoring of CAR-T cell dynamics in vivo is crucial but currently lacks readily translatable imaging techniques.
Purpose of the Study:
- To address the need for noninvasive imaging methods to visualize CAR-T cells in vivo.
- To highlight positron emission tomography (PET) as an ideal tool for monitoring CAR-T cell therapy.
Main Methods:
- Review of current limitations in CAR-T cell imaging.
- Discussion of the potential of noninvasive PET imaging for CAR-T cell tracking.
Main Results:
- Existing imaging approaches for CAR-T cells are not readily translatable for clinical use.
- Noninvasive PET imaging offers a promising solution for real-time monitoring of CAR-T cell distribution and behavior.
Conclusions:
- There is a significant gap in noninvasive imaging techniques for CAR-T cell therapy.
- PET imaging presents a viable and ideal modality for visualizing and monitoring CAR-T cells in vivo, facilitating treatment optimization.
